Skip to content

Effects of Transcutaneous Vagus Nerve Stimulation in Chronic Pain Patients and Healthy Controls

Unknown statusNot applicableNCT05007743
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The tVNS-PP trial investigates the effects of transcutaneous vagus nerve stimulation (tVNS) on autonomic functions, immune responses, and disease severity in chronic pain and restless legs syndrome (RLS) patients as compared to healthy controls.

Study details

Official title
Randomized Trial of Effects of Transcutaneous Vagus Nerve Stimulation in Chronic Pain Patients and Healthy Controls
Conditions
Interventions
  • Device: Transcutaneous vagus nerve stimulation
Sponsor
University Medical Center Goettingen
Start date
2019-07-21
Primary completion
2023-08
Sex
All
Age range
from 18 Years to 80 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
Germany
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion criteria: * Male and female participants between 18 and 80 years old * Written informed consent Exclusion criteria: * Age younger than 18 years or older than 80 years * Participants with somatic or mental comorbidities, especially malignant tumor diseases, cardiac insufficiencies \> NYHA II, severe depressive episodes, psychosis or dementia * Pregnancy or breast feeding * Addictions to alcohol, medications or drugs (except tobacco) * An existing legal guardianship * Participation in another scientific study within the previous eight weeks before enrollment * Restless Legs Syndrome patients with one of the following secondary predispositions: iron deficiency, polyneuropathy, prolapsed disk, spinal stenosis or chronic obstructive pulmonary disease

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05007743